1Department of Oncology, Mayo Clinic, Rochester, Minnesota.
President Donald Trump has issued a number of executive orders (EO) focused on healthcare for people who identify as lesbian, gay, bisexual, transgender, queer, or other sexual or gender minority.
Copyright held by the owner/author(s). This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International ...
1Department of Radiation Oncology, The University of Texas Southwestern Medical Center at Dallas, Dallas, Texas. 2Department of Biochemistry, The University of Texas Southwestern Medical Center at ...
LY3866288, an FGR3-specific inhibitor, led to an objective response in 42% of patients with metastatic urothelial carcinoma in a phase I study. The drug did not induce adverse events more commonly ...
The EZH2 inhibitor mevrometostat, in combination with the androgen receptor signaling inhibitor enzalutamide, improved progression-free survival and objective response rates in patients with ...
1i3S—Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal. 2Faculdade de Medicina, Universidade do Porto, Porto, Portugal.
Cancer Grand Challenges, Cancer Research UK, London, United Kingdom.
Francis Collins, MD, PhD, announced his retirement from the NIH, which he joined in 1993 and led from 2009 to 2021, making him the longest-serving director. He led the Human Genome Project, which, ...
1Department of Medicine, Cedars-Sinai Medical Center, Cedars-Sinai Cancer Institute, Los Angeles, California. 2Department of Biomedical Sciences, Cedars-Sinai Medical Center, Cedars-Sinai Cancer ...
1Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback